We use analytics cookies to give us insight into how our website is being used. Learn more in our cookie notice I Accept +

+44 (0) 20 3997 7634 | sales@fbkmed.com

A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).

A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).

31/05/14
Back To News +

Latest Articles

Interim results for the six months ended 30 November 2022

07/02/23

Bleepa Feedback Medical Feedback PLC

Annual Results: New strategic direction delivers growth in Bleepa sales

20/09/22

Bleepa Feedback Medical Feedback PLC

Feedback awarded 12-month contract for pilot extension in Sussex CDC

06/09/22

Bleepa Feedback Medical Feedback PLC